Infliximab in postoperative recurrence in CD
Adalimumab in paediatric CD
Mesalazine in UC once or twice daily
Profermin is efficacious in patients with active ulcerative colitis–a randomized controlled trial
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn’s Disease
Secukinumab in mode-severe CD
Infliximab stop in CD
Infliximab switch to adalimumab in CD
Tacrolimus in steroid dependent UC
Adalimumab in UC